Increasingly health economic evidence is essential for products to be commissioned and gain adoption.
SEHTA are delighted to bring you this webinar session with HecoAnalytics Ltd who provide a web-based economic decision making tool that allows a company to make instant health economic assessment of their product portfolio and that allows for different scenario planning in response to new development, clinical or market data.
Date: Wednesday 5th June 2024
Time: 11:00 – 12:00 (BST)
Platform: TEAMS
FREE TO ATTEND
HecoAnalytics has an easy-to-use health analytics platform supporting MedTech companies on a personalised health economics (HE) journey.
HecoAnalytics facilitation sessions start this journey and support companies with a suite of configurable tools that synthesise evidence data, AI pathway and patient models with online health economic models. HecoAnalytics models grow in complexity over the course of each company’s HE journey as evidence and evaluations progress.
Presenter – Dr Stuart Hendry, CEO, HecoAnalytics Ltd
Stuart will cover –
- The need for health economic evidence to sell medtech
- Novel web tools for evolving health economic support
- Leveraging computing technologies for democratisation of health economics for developers and commissioners
- Secure cloud-based platform delivering visual health economics for innovators and commissioners
- Automated health data analysis using the latest AI techniques
Target audience
C-suite executives in medtech and digital health companies; Product developers; Investors in medtech and digital health; Institutions involved in medtech and digital health venturing, accelerators and incubation; Commissioners of medtech and digital health technology
Click here to register your place.